US Patent Issued to AURELIUS BIOTHERAPEUTICS on Aug. 5 for "Cell therapy compositions and methods of use thereof" (Washington Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,522, issued on Aug. 5, was assigned to AURELIUS BIOTHERAPEUTICS LLC (Bellingham, Wash.).

"Cell therapy compositions and methods of use thereof" was invented by Edmund Sullivan (Bellingham, Wash.) and Theresa Westfall (Bellingham, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compositions of immune cells presenting a target molecule or a fragment thereof and provides compositions and methods of producing immune cell therapies with targeted activity against cancer. Methods for conditioning a subject receiving the immune cell therapy of the disclosure are additionally disclosed. The immune cell therapies of the pre...